By Editor

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath them. The markets had opened in the red but were trending upward all morning.…

REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?

Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a…

By Editor

VRTX: Vertex Pharmaceuticals – Buy or Sell This Biotech Beast?

Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market…

By Editor

The Biotech Bonanza: A Wild Ride Through the Stock Market Jungle

Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle…

By Editor

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From It

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From ItPalantir (PLTR)’s earnings…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt…

By Editor
5 Min Read

My Top 3 Stocks in Healthcare AI and Digital Health

AI is shaking up healthcare — cutting costs, speeding diagnoses, and transforming…

By Editor
6 Min Read

A Guide to Using X as a Day or Swing Trader

If you're trading FOMC events or chasing fast market moves, X (formerly…

By Editor
9 Min Read

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From It

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn…

By Editor
8 Min Read

My Top 3 Stocks in Healthcare AI and Digital Health

AI is shaking up healthcare — cutting costs, speeding diagnoses, and transforming entire fields. From virtual…

By Editor

A Guide to Using X as a Day or Swing Trader

If you're trading FOMC events or chasing fast market moves, X (formerly Twitter) is your real-time…

By Editor

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From It

Why Palantir (PLTR) Has Been Soaring — And What Traders Can Learn From ItPalantir (PLTR)’s earnings…

By Editor

META: Meta Platforms Stock – Buy or Sell This Social Star?

Meta Platforms (META) is the social media diva turned AI visionary, voguing at $585.71 (StockAnalysis.com) as of March 26, 2025.…

By Editor
2 Min Read